Abstract
Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying other anti-HBV agents with specific, but distinctive mechanisms of action are needed. The human La (hLa) protein, which forms a stabilizing complex with HBV RNA ribonucleoprotein to promote HBV replication, is a promising target of molecular therapy. This study aimed to discover novel inhibitors of hLa that could inhibit HBV replication and expression. A multistage molecular docking approach was used to screen a Specs database and an in-house library against hLa binding sites. Sequential in vitro evaluations were performed to detect potential compounds with high scores in HepG2.2.15 cells. Of the 26 potential compounds with high scores chosen for experimental verification, 12 had HBV DNA inhibition ratios of less than 50% with P<0.05. Six had significant inhibition of HBV e antigen (HBeAg) levels, and 13 had significant inhibition of HBV surface antigen (HBsAg) levels by in vitro assays. Compounds HBSC-11, HBSC-15 and HBSC-34 (HBSC is system pref...Continue Reading
References
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M A SellsG Acs
Jan 1, 1985·Hematological Oncology·S H LevittG Frizzera
Jul 1, 1995·Molecular and Cellular Biology·Z M Huang, T S Yen
Sep 14, 1994·Journal of Immunological Methods·A A van de LoosdrechtM M Langenhuijsen
Jul 1, 1996·Journal of Virology·J E DonelloT J Hope
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Jun 11, 1999·Journal of Virology·T HeiseF V Chisari
Dec 23, 2000·The Journal of General Virology·K SpångbergS Schwartz
Jan 3, 2001·Molecular and Cellular Biology·R J Maraia, R V Intine
Jul 4, 2001·Journal of Virology·T HeiseF V Chisari
Jul 18, 2002·The Journal of Biological Chemistry·Sven HorkeTilman Heise
Mar 16, 2004·Journal of Virology·Raquel E IzumiAsim Dasgupta
Mar 19, 2004·Journal of Medicinal Chemistry·Richard A FriesnerPeter S Shenkin
Jul 9, 2004·World Journal of Gastroenterology : WJG·Qin NiLing-Ling Wu
Aug 11, 2004·The Journal of Biological Chemistry·Imke EhlersTilman Heise
Jan 3, 2006·Molecular Cell·Marianna TeplovaDinshaw J Patel
Aug 10, 2007·BMC Biochemistry·Stephen M T HokeChristopher J Brandl
Jun 13, 2008·Structure·Olga Kotik-KoganStephen Curry
Mar 12, 2009·Infectious Disorders Drug Targets·Lance L Stein, Rohit Loomba
May 8, 2009·Journal of Medicinal Chemistry·Chien-Shu ChenJi-Wang Chern
Jun 25, 2010·RNA·Katrin SchäfflerUtz Fischer
Jul 16, 2010·Bioorganic & Medicinal Chemistry·Tanaji T TaleleNeerja Kaushik-Basu
Nov 17, 2010·Journal of Experimental & Clinical Cancer Research : CR·Zhong-Jun WuZhi-Qiang Wang
May 3, 2011·Bioorganic & Medicinal Chemistry Letters·Nam Doo KimSoon Kil Ahn
May 17, 2011·Current Medicinal Chemistry·G Melagraki, A Afantitis
Citations
Jul 8, 2014·PloS One·Xia JiangOsamu Yokosuka
Nov 10, 2013·Future Microbiology·Armando AriasIan Goodfellow
Nov 2, 2012·Cancer Metastasis Reviews·Mausumi BharadwajShowket Hussain
Sep 22, 2015·Viruses·Lei KangJing Tang
Dec 13, 2012·Journal of Viral Hepatitis·J TangG-L Liu
Nov 21, 2012·Fitoterapia·Li-Peng Qiu, Ke-Ping Chen
Mar 16, 2017·PloS One·Gunhild SommerTilman Heise
Nov 2, 2017·Journal of Viral Hepatitis·J PanJ Tang
Sep 9, 2017·Journal of Medical Virology·Jiaqian PanJing Tang
Apr 10, 2015·Journal of Virology·Surender VashistIan Goodfellow
Jul 21, 2020·RNA Biology·Gunhild Sommer, Tilman Heise
Oct 27, 2016·Current Opinion in Infectious Diseases·Jiaqian PanJing Tang
Jun 27, 2019·Journal of Medical Virology·Shuangmei TongJing Tang
Oct 31, 2015·Molecular Biology Reports·Akasit VisootsatNattanan P T-Thienprasert
Aug 26, 2016·Virus Genes·Jie LiuShifeng Yun
Sep 23, 2020·International Journal of Molecular Sciences·Jonas WeißeTony Gutschner